US EditionPublished • loading... • Updated
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Uncovering A 19.81% Upside Potential
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Uncovering A 19.81% Upside Potential
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, specifically within the drug manufacturing industry, is attracting significant attention from investors due to its promising growth prospects. With a market capitalization of $1.24 billion, Amphastar has carved out a niche in developing, manufacturing, and marketing generic and proprietary injectable, inhalation, and intranasal products. **Current Price Dy…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
